Key Data Files for this Active Pharmaceutical Ingredient:

Drug Master Files, 21 CFR, and other industry portals Patent/Exclusivity data file Drug Approval Drug Safety Freedom of Information Federal Register pages Pharma Companies Pharmacopeial Information Preferred API Supplier (Clients Only)

FDA Approval Activities for this Drug… Rescriptor (delavirdine) Tablet, 100 & 200mg Agouron 20-705/S-009 3/14/02 3/29/02 Rescriptor (delavirdine mesylate) Tablet, Agouron NDA 20-705/S-008 5/16/01 7/24/03 5/16/01 Rescriptor (delavirdine mesylate) Tablet, 200mg Pharmacia & Upjohn Company 20-705/S-003 7/14/99 7/28/99 7/28/99 Rescriptor Indication:For the treatment of HIV-1 infection in combination with appropriate antiretroviral agents.   For the latest approval information, locate this drug using this index.